SPOTLIGHT -
Sales of leukemia chemotherapy drug suspended
Citing the risk of life-threatening blood clots and severe narrowing of blood vessels, FDA has asked Ariad Pharmaceuticals to suspend marketing and sales of ponatinib (Iclusig).